1-4 of 4
Jerald Z. Gong
Close
Sort by
Journal Articles

Brentuximab vedotin in the treatment of CD30 + PTCL

Clinical Trials & Observations
Stefan K. Barta, Jerald Z. Gong, Pierluigi Porcu
Journal: Blood
Blood (2019) 134 (26): 2339–2345.
https://doi.org/10.1182/blood.2019001821
Published: 2019
Journal Articles

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Keith M. Sullivan, MD, Mitchell Horwitz, MD, John Chute, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Cong Xiao Lu, MD, Dawn Marshall, BS, Jeanette M. Dowell, MS, Nelson J. Chao, MD
Journal: Blood
Blood (2005) 106 (11): 2896.
https://doi.org/10.1182/blood.V106.11.2896.2896
Published: 2005
Journal Articles

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Keith M. Sullivan, MD, John Chute, MD, Mitchell Horwitz, MD, Morris Ashley, PharmD, Nelson J. Chao, MD
Journal: Blood
Blood (2005) 106 (11): 2036.
https://doi.org/10.1182/blood.V106.11.2036.2036
Published: 2005
Journal Articles

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors

Roberto Chiarle, Jerald Z. Gong, Ilaria Guasparri, Anna Pesci, Jonjing Cai, Jian Liu, William J. Simmons, Girish Dhall, Jennifer Howes, Roberto Piva, Giorgio Inghirami
Journal: Blood
Blood (2003) 101 (5): 1919–1927.
https://doi.org/10.1182/blood-2002-05-1343
Published: 2003